NDC 55513-190 – Neulasta

Pegfilgrastim 6 mg/.6mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC55513-190

Product details

Brand name
Neulasta
Generic name
Pegfilgrastim
Labeler
Amgen, Inc
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA125031
Marketed since
April 1, 2002
Listing expires
December 31, 2027
Pharmacologic class
Leukocyte Growth Factor

Active ingredients

Uses, dosage, side effects and warnings for Neulasta →

Package NDC codes (1)

Package NDCDescriptionSince
55513-190-011 SYRINGE in 1 CARTON (55513-190-01) / .6 mL in 1 SYRINGEApr 1, 2002

Other Neulasta products